Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Tenax Therapeutics (TENX) Other Non Operating Income (2016 - 2017)

Tenax Therapeutics' Other Non Operating Income history spans 7 years, with the latest figure at $693941.0 for Q4 2017.

  • For Q4 2017, Other Non Operating Income fell 49.17% year-over-year to $693941.0; the TTM value through Dec 2017 reached $366216.0, down 75.78%, while the annual FY2025 figure was -$33000.0, 3400.0% down from the prior year.
  • Other Non Operating Income for Q4 2017 was $693941.0 at Tenax Therapeutics, up from -$76225.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.4 million in Q4 2016 and bottomed at -$250097.0 in Q1 2013.
  • The 4-year median for Other Non Operating Income is $914.0 (2016), against an average of $292167.7.
  • The largest annual shift saw Other Non Operating Income plummeted 201.87% in 2013 before it soared 66.41% in 2017.
  • A 4-year view of Other Non Operating Income shows it stood at -$250097.0 in 2013, then surged by 617.17% to $1.3 million in 2015, then rose by 5.56% to $1.4 million in 2016, then plummeted by 49.17% to $693941.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Other Non Operating Income are $693941.0 (Q4 2017), -$76225.0 (Q3 2017), and -$28199.0 (Q2 2017).